HomeNKTR • NASDAQ
Nektar Therapeutics
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 29.18M | 22.15% |
Operating expense | 45.88M | -2.92% |
Net income | 7.26M | 117.26% |
Net profit margin | 24.89 | 114.13% |
Earnings per share | -0.15 | 31.82% |
EBITDA | -24.35M | 16.06% |
Effective tax rate | -3.70% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 255.23M | -15.94% |
Total assets | 303.85M | -23.66% |
Total liabilities | 243.11M | -8.96% |
Total equity | 60.74M | — |
Shares outstanding | 186.10M | — |
Price to book | 2.00 | — |
Return on assets | -20.17% | — |
Return on capital | -24.20% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 7.26M | 117.26% |
Cash from operations | -46.19M | 1.83% |
Cash from investing | 60.21M | 246.40% |
Cash from financing | 83.00K | 591.67% |
Net change in cash | 14.14M | 147.71% |
Free cash flow | 14.28M | 186.47% |
Previous close
$0.66
Day range
$0.58 - $0.66
Year range
$0.58 - $1.93
Market cap
109.49M USD
Avg Volume
1.68M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1990
Headquarters
Website
Employees
61
